ClinicalTrials.gov
public full text
Public Domain
Study of Enfuvirtide in HIV-Positive Subjects
A total of 26 patients will be admitted to the clinic where they will be dosed with each injection device. There will be a 7-day washout between doses and a 7-10 day follow-up period.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- WHO guideline for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia: web annex B: evidence-to-decision tables#379678
- Mechanisms Relating to the Distinct in Vitro Susceptibility of Human Macrophages to L. Viannia Infection#898539
- Single Dose, Weight-Based, Dose-Escalation Study With Intravenous ETI-204 in Adult Volunteers#875842
- HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults#1245365
- LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept Study#912891
Record · ID 1259385
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive